Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr. Ginsburg is the founding director for the Center for Applied Genomics & Precision Medicine at the Duke University Medical Center and for MEDx, a partnership between the Schools of Medicine and Engineering to spark and translate innovation. His research addresses the challenges for translating genomic and digital health information into medical practice and the integration of precision medicine into healthcare. In 2017 he received Duke’s Translational Research Mentorship Award and is a finalist in the NIH/BARDA Antimicrobial Resistance Prize.

He was a member of the Advisory Council to the Director of NIH and is co-chair of the National Academies Roundtable on Genomic and Precision Health and is founder and president of the Global Genomic Medicine Collaborative, a not for profit organization aimed creating international partnerships to advance the implementation of precision medicine. He has recently served as a member of the Board of External Experts for the NHLBI, the advisory council for the National Center for Accelerating Translational Science, chair of the review for Genome Canada’s Large Scale Applied Research Competition in Genomics and Precision Medicine, and the World Economic Forum’s Global Agenda Council on the Future of the Health Sector.  He is a founder of Predigen, Inc and MeTree&You, Inc.  He was previously Vice President of Molecular Medicine at Millennium Pharmaceuticals, Inc and a faculty member at Harvard Medical School.

He is the founder and co-chair of the Global Genomic Medicine Collaborative, a not-for-profit (501c(3)) dedicated to implementing genomic medicine with a focus on low resource settings around the globe.  The G2MC operates the International 100K+ Cohorts Consortium of which he is one of the co-chairs along with Teri Manolio (NHGRI) and Peter Goodhand (GA4GH).

Forthcoming events

The epidemiology of periportal fibrosis in the context of intestinal schistosomiasis

Monday, 09 October 2023, 1pm to 2pm @ BDI/OxPop Building seminar rooms

Defeating Meningitis by 2023 Global Roadmap

Monday, 16 October 2023, 1pm to 2pm @ BDI/OxPop Building seminar room 1

OxPop Festival of Global Health - The Cancer Conflict

Thursday, 19 October 2023, 5pm to 8pm @ Richard Doll Lecture Theatre, Richard Doll Building, Roosevelt Drive, Oxford, OX3 7LF

Cancer Treatments: trust and information

Chronic infections and risk of NCDs in Chinese adults

Monday, 30 October 2023, 1pm to 2pm @ BBDI/OxPop Building seminar rooms

Metabolomics and diabetes in CKB and UKB

Thursday, 02 November 2023, 12pm to 1pm @ BDI/OxPop Building LG seminar room 0